Top compounds associated with response to ZNF766


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA sotrastaurin CTRPv2 pan-cancer AAC 0.24 7e-09
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 8e-09
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-08
mRNA SU11274 CTRPv2 pan-cancer AAC 0.21 2e-08
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 5e-08
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.18 6e-08
mRNA decitabine CTRPv2 pan-cancer AAC 0.16 9e-08
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.16 1e-07
mRNA Axitinib CTRPv2 pan-cancer AAC 0.19 2e-07
Download CSV